AR-C165395XX
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AR-C165395XX, covering 2016-06-23 to 2016-06-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1]